- Home
- ETON vs MBAV Comparison
ETON vs MBAV Comparison
Compare ETON & MBAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- MBAV
- Stock Information
- Founded
- ETON 2017
- MBAV 2024
- Country
- ETON United States
- MBAV United States
- Employees
- ETON N/A
- MBAV N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- MBAV
- Sector
- ETON Health Care
- MBAV
- Exchange
- ETON Nasdaq
- MBAV NYSE
- Market Cap
- ETON 428.5M
- MBAV 368.4M
- IPO Year
- ETON 2018
- MBAV 2024
- Fundamental
- Price
- ETON $17.07
- MBAV $10.40
- Analyst Decision
- ETON Strong Buy
- MBAV
- Analyst Count
- ETON 3
- MBAV 0
- Target Price
- ETON $27.67
- MBAV N/A
- AVG Volume (30 Days)
- ETON 231.3K
- MBAV 125.0K
- Earning Date
- ETON 05-13-2025
- MBAV 01-01-0001
- Dividend Yield
- ETON N/A
- MBAV N/A
- EPS Growth
- ETON N/A
- MBAV N/A
- EPS
- ETON N/A
- MBAV 0.24
- Revenue
- ETON $39,011,000.00
- MBAV N/A
- Revenue This Year
- ETON $92.33
- MBAV N/A
- Revenue Next Year
- ETON $54.19
- MBAV N/A
- P/E Ratio
- ETON N/A
- MBAV $43.65
- Revenue Growth
- ETON 23.29
- MBAV N/A
- 52 Week Low
- ETON $3.18
- MBAV $9.97
- 52 Week High
- ETON $18.41
- MBAV $10.91
- Technical
- Relative Strength Index (RSI)
- ETON 62.16
- MBAV N/A
- Support Level
- ETON $16.43
- MBAV N/A
- Resistance Level
- ETON $17.74
- MBAV N/A
- Average True Range (ATR)
- ETON 0.92
- MBAV 0.00
- MACD
- ETON 0.06
- MBAV 0.00
- Stochastic Oscillator
- ETON 73.09
- MBAV 0.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About MBAV M3-BRIGADE ACQUISITION V CORP
M3-Brigade Acquisition V Corp is a blank check company.